NL-OMON21289
Recruiting
Not Applicable
Determination of new biomarkers in patients with resectable colorectal liver metastases
Prof. Dr. C. Verhoef Erasmus, Head of department of Surgical Oncology, MC Cancer Institute Groene Hilledijk 301, 3075 EA, Rotterdam0 sites240 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Prof. Dr. C. Verhoef Erasmus, Head of department of Surgical Oncology, MC Cancer Institute Groene Hilledijk 301, 3075 EA, Rotterdam
- Enrollment
- 240
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \= 18 years.
- •Histologically confirmed primary colorectal carcinoma.
- •Radiological confirmed and resectable liver metastasis of colorectal cancer, planned to undergo resection with or without neo\-adjuvant chemotherapy.
- •Before patient registration, written informed consent must be given according to ICH/GCP, and national/local regulations.
Exclusion Criteria
- •Prior adjuvant chemotherapy for the primary colorectal carcinoma given \<6 months prior to detection of the liver metastases.
- •Second primary malignancy within the past 5 years with the exception of adequately treated in situ carcinoma of any organ or basal cell carcinoma of the skin.
- •Presence of extrahepatic disease. Patients with small (\=1 cm) extrahepatic lesions that are not clearly suspicious of metastases are eligible.
- •Females with a positive pregnancy test (within 14 days before treatment start).
- •History of psychiatric disability judged by the investigator to be clinically significant, precluding informed consent.
- •Current or recent treatment with another investigational drug or participation in another investigational study.
- •Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow\-up schedule; those conditions should be discussed with the patient before registration in study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Determination of new biomarkers in patients with resectable colorectal liver metastases, the MIRACLE studycolorectal liver metastases10027476NL-OMON50622Erasmus MC, Universitair Medisch Centrum Rotterdam240
Recruiting
Not Applicable
Detection of novel biomarkers in patients with interstitial pneumonia or acute exacerbation of interstitial pneumonia.Patients with interstitial pneumonias or acute exacerbation of interstitial pneumoniasJPRN-UMIN000044825Hamamatsu University School of Medicine300
Recruiting
Not Applicable
Clinical research for biomarkers in patients with drug-induced lung injury and their clinical significanceCases of suspected drug-induced lung injury and performed bronchoalveolar lavage for diagnosticJPRN-UMIN000033951niversity of Occupational and Environmental Health, Department of Respiratory Medicine60
Recruiting
Not Applicable
Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adultsG47Sleep disordersDRKS00030981Charitè Universitätmedizin (Chronobiology Lab)32
Not yet recruiting
Not Applicable
Detection of prognostic biomarkers in patients with oral squamous cell carcinoma with tissue microarrayOral Squamous Cell CarcinomaC01C02C03C04C05C06Malignant neoplasm of base of tongueMalignant neoplasm of other and unspecified parts of tongueMalignant neoplasm of gumMalignant neoplasm of floor of mouthMalignant neoplasm of palateMalignant neoplasm of other and unspecified parts of mouthDRKS00010431niversitätsklinikum Hamburg-Eppendorf1,000